Revital Aricha

The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.

H. Scott, S. Fuchs, S. Berrih-Aknin, 2011, Journal of autoimmunity.

Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.

S. Fuchs, M. C. Souroujon, Revital Aricha, 2014, Journal of autoimmunity.

Age dependent course of EAE in Aire−/− mice

S. Fuchs, R. Arnon, R. Eilam, 2013, Journal of Neuroimmunology.

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis

S. Fuchs, S. Berrih-Aknin, I. Shachar, 2016, Oncotarget.

Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia Gravis1

S. Fuchs, T. Feferman, M. C. Souroujon, 2008, The Journal of Immunology.

Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor

S. Fuchs, T. Feferman, M. C. Souroujon, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Erythropoietin Ameliorates Experimental Autoimmune Myasthenia Gravis

S. Fuchs, M. C. Souroujon, D. Neumann, 2015 .

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.

S. Fuchs, M. C. Souroujon, Revital Aricha, 2011, Journal of autoimmunity.